The Natural Alkaloid Bousigonine D Improves Insulin Sensitivity and Glucose Homeostasis through Concurrent PI3K/AKT and AMPK Activation
Year: 2026
Type: preprint
Abstract: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder driven primarily by insulin resistance and disordered glucose and lipid metabolism, which poses a substantial global health and economic burden. This study was designed to evaluate the therapeutic potential of Bousigonine D (BSG-D), a monoterpenoid indole alkaloid from Bousigonia mekongensis, and to elucidate its underlying mechanisms in ameliorating insulin resistance and associated metabolic dysregulation in T2DM. Using a combination of in vivo (high-fat diet plus streptozotocin-induced diabetic mouse model) and in vitro (HepG2 insulin-resistant cell model) experimental approaches, along with biochemical assays, histopathological examination, and analysis of protein expression, we found that administration of BSG-D induced a rapid reduction in blood glucose levels within 6 hours in diabetic mice and improved systemic glucose homeostasis, as demonstrated by enhanced performance in both oral glucose tolerance and insulin tolerance tests. BSG-D treatment also effectively modulated serum lipid profiles, lowering total cholesterol and free fatty acids levels. Histopathological examination revealed that BSG-D ameliorated pancreatic and hepatic damage, characterized by improved cellular architecture and diminished inflammatory infiltration. Consistent with these effects in vivo, as shown by decreased serum insulin levels and a reduced HOMA-IR index, BSG-D restored glucose consumption in insulin-resistant HepG2 cells. These findings highlight the multifaceted therapeutic potential of BSG-D in T2DM management, supporting its promise as a novel therapeutic agent. Future studies should prioritize clinical validation and incorporate multi-omics strategies to further elucidate the mechanisms of action of BSG-D and advance its application in T2DM treatment.
Source: Research Square
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G1549057574, G241206937
OpenAlex ID: W7234541877
